Literature DB >> 1861074

Natural killer cell clones can efficiently process and present protein antigens.

M G Roncarolo1, M Bigler, J B Haanen, H Yssel, R Bacchetta, J E de Vries, H Spits.   

Abstract

NK cell clones obtained from three different donors were tested for their ability to present soluble proteins to Ag-specific T cell clones. All NK clones were CD2+CD3-CD56+, whereas the expression of CD16 varied from clone to clone. The NK cell clones were able to process and present tetanus toxoid (TT) to TT-specific T cell clones in a class II HLA restricted manner. The capacity of NK cell clones to function as APC was also observed using the house dust mite allergen Der p I and the Der p I-derived peptide Val89-Cys117. As with EBV-transformed B cell line, NK cell clones could present the peptide 3-13 derived from the 65-kDa heat shock protein of Mycobacterium leprae, but they were unable to present the whole M. leprae Ag. Freshly isolated NK cells, IL-2-activated NK cells, and NK cell lines expanded in vitro could also process and present TT. The ability of the different NK populations to act as accessory cells correlated with their levels of class II HLA expression. These data demonstrate that NK cell clones can efficiently function as APC, however they may be restricted in the types of Ag that they can process.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1861074

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  CD11c identifies a subset of murine liver natural killer cells that responds to adenoviral hepatitis.

Authors:  Bryan M Burt; George Plitas; Jennifer A Stableford; Hoang M Nguyen; Zubin M Bamboat; Venu G Pillarisetty; Ronald P DeMatteo
Journal:  J Leukoc Biol       Date:  2008-07-29       Impact factor: 4.962

2.  Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4.

Authors:  Jeffrey M Milush; Brian R Long; Jennifer E Snyder-Cappione; Amedeo J Cappione; Vanessa A York; Lishomwa C Ndhlovu; Lewis L Lanier; Jakob Michaëlsson; Douglas F Nixon
Journal:  Blood       Date:  2009-10-05       Impact factor: 22.113

Review 3.  Regulation of adaptive immunity by natural killer cells.

Authors:  F J Kos
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

4.  HLA-DR+ NK cells are mostly characterized by less mature phenotype and high functional activity.

Authors:  Sofya A Erokhina; Maria A Streltsova; Leonid M Kanevskiy; William G Telford; Alexander M Sapozhnikov; Elena I Kovalenko
Journal:  Immunol Cell Biol       Date:  2017-12-19       Impact factor: 5.126

5.  Mycoplasma arthritidis mitogen up-regulates human NK cell activity.

Authors:  J A D'Orazio; B C Cole; J Stein-Streilein
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

6.  Marked differences in CCR5 expression and activation levels in two South African populations.

Authors:  Anabela C P Picton; Sharon Shalekoff; Maria Paximadis; Caroline T Tiemessen
Journal:  Immunology       Date:  2012-08       Impact factor: 7.397

7.  Natural killer (NK)-dendritic cell interactions generate MHC class II-dressed NK cells that regulate CD4+ T cells.

Authors:  Masafumi Nakayama; Kazuyoshi Takeda; Mitsuko Kawano; Toshiyuki Takai; Naoto Ishii; Kouetsu Ogasawara
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-31       Impact factor: 11.205

8.  Supplementation with selenium augments the functions of natural killer and lymphokine-activated killer cells.

Authors:  L Kiremidjian-Schumacher; M Roy; H I Wishe; M W Cohen; G Stotzky
Journal:  Biol Trace Elem Res       Date:  1996-06       Impact factor: 3.738

9.  Chimerism and tolerance to host and donor in severe combined immunodeficiencies transplanted with fetal liver stem cells.

Authors:  R Bacchetta; B A Vandekerckhove; J L Touraine; M Bigler; S Martino; L Gebuhrer; J E de Vries; H Spits; M G Roncarolo
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

10.  Both conventional and interferon killer dendritic cells have antigen-presenting capacity during influenza virus infection.

Authors:  Corine H GeurtsvanKessel; Ingrid M Bergen; Femke Muskens; Louis Boon; Henk C Hoogsteden; Albert D M E Osterhaus; Guus F Rimmelzwaan; Bart N Lambrecht
Journal:  PLoS One       Date:  2009-09-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.